By Michelle Toh, CNN Business

The US is getting its first listed offering from a Chinese company in several months, although tensions between the US and China and regulatory control remain high.

Meihua International Medical Technologies, which sells medical supplies worldwide, is expected to debut this week on the Nasdaq in New York.

The health company is seeking to raise $ 57.5 million according to data prepared for the New York Stock Exchange.

Although the amount is relatively small, it would mark the first listing of a Chinese company since October, when the biotech company LianBio raised $ 334 million on the same stock exchange, according to data provider Dealogic.

LianBio is headquartered in both USA and China. U.S. investors have not seen a listing from a company headquartered in China since July, then Sentage Holdingsa Shanghai-based financial services provider, was listed on the Nasdaq.

There was only one U.S. listing from a Chinese company from August to January compared to 20 in the same period a year ago, according to Dealogic.

China has tightened restrictions on companies hoping to be listed abroad after one fateful stock exchange listing by the country’s dominant ride-hailing provider, Didi, last summer.

The company was listed in June in the largest U.S. listing from a Chinese company since Alibaba’s debut in 2014, raising about $ 4.4 billion.

But just two days later, China launched a probe into Didi and suspended the registration of new users on its app, sweeping it into a major repression of the country’s technology sector.

Beijing’s decision to target Didi was broadly speaking as punishment for its decision to go public abroad, and the company became a poster child of China’s efforts to curb what the government sees as unruly Big Tech companies.

Since then both securities and data controllers in China has rolled out new proposed rules for companies wishing to be listed elsewhere in the world. For example, Chinese authorities have suggested that companies with data on more than 1 million users seek approval before being listed abroad.

In December, Didi said it would delist from the New York Stock Exchange and move its public offering to Hong Kong.

However, Meihua’s upcoming IPO in the US may signal the beginning of a new wave of action.

In recent weeks, a handful of firms with predominantly Chinese activities have applied for IPOs on Wall Street, according to application with the US Securities and Exchange Commission.

– CNN’s Beijing Bureau and Laura He contributed to this report.

™ & © 2022 Cable News Network, Inc., a WarnerMedia company. All rights reserved.